EDP-1503

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameEDP-1503
Drug Alias NameEDP-1503
ClassificationBiologics
Mechanisms of ActionImmunomodulatorsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsMicrosatellite InstabilityUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Chicago
China Registration ClassN/A

Develop Information

Active CompaniesEvelo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsMicrosatellite InstabilityUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A